| Forsythoside E | 93675-88-8 | C20H30O12 |
| Forsythoside G | 129802-19-3 | C35H46O19 |
| Fosamprenavir-d4 Calcium Salt | Not available | C25H34CaN3O9PS |
| Fosaprepitant | 172673-20-0 | C23H22F7N4O6P |
| Fosaprepitant Impurity 3 | 265121-01-5 | C37H34F7N4O6P |
| Fosaprepitant Impurity 4 | 889852-02-2 | C30H28F7N4O6P |
| Fosaprepitant Impurity 5 | 502537-07-7 | C13H12F3NO4 |
| Fosaprepitant Impurity 6 | 378223-36-0 | C11H13NO3 |
| Fosaprepitant Impurity 7 | 13657-16-4 | C10H13NO |
| Fosaprepitant Impurity 8 | 30071-93-3 | C10H6F6O |
| Fosaprepitant Impurity 10 | 502537-15-7 | C21H19F6NO3 |
| Fosaprepitant Impurity 11 | 1651828-04-4 | C27H24F7NO3 |
| Fosaprepitant Impurity 13 | 327623-34-7 | C21H19F6NO3 |
| Fosaprepitant Impurity 15 | 502537-39-5 | C20H20F7NO3 |
| Fosaprepitant Impurity 16 | 24021-90-7 | C3H5N3O2 |
| Fosaprepitant Impurity 16 | 2410426-96-7 | C14H13F6NO3 |
| Fosaprepitant Impurity 17 | 172678-47-6 | C20H18F7NO2 |
| Fosaprepitant Impurity 18 | 1623-07-0 | C7H9O4P |
| Fosaprepitant Impurity 20 | 1707-92-2 | C21H21O4P |
| Fosaprepitant Impurity 24 | 172673-19-7 | C23H22F7N4O6P |
| Fosaprepitant Impurity 25 | 380499-07-0 | C20H16F7NO2 |
| Fosaprepitant Impurity 36 | 990-91-0 | C28H28O7P2 |
| Foscarnet Impurity B | 55920-24-6 | C3H5Na2O5P |
| Foscarnet Impurity B | 55920-24-6 | C3H5Na2O5P |
| Foscarnet impurity D | 1474-78-8 | C7H15O5P |
| Foscarnet Related Compound D | 1474-78-8 | C7H15O5P |
| Foscarnet Sodium EP Impurity A | 72305-00-1 | C3H5Na2O5P |
| Foscarnet Sodium EP Impurity D | 1474-78-8 | C7H15O5P |
| Foscarnet sodium hexahydrate | 34156-56-4 | CH12Na3O11P |
| Foscarnet Sodium Hexahydrate Imp. D (EP): Ethyl (Diethoxyphosphoryl)formate | 1474-78-8 | C7H15O5P |
| Fosfluconazole | 194798-83-9 | C13H13F2N6O4P |
| Fosfluconazole Impurity 1 | 1774-47-6 | C3H9IOS |
| Fosfomycin | 23155-02-4 | C3H7O4P |
| Fosfomycin Diastereomer Impurity 2 | 45629-00-3 | C3H7O4P |
| Fosfomycin Enantiomer Impurity | 26017-03-8 | C3H7O4P |
| Fosfomycin Impurity 14 | 1416734-33-2 | C6H14O8P2 |
| Fosfomycin Impurity 15 | 25460-63-3 | C5H11O4P |
| Fosfomycin Impurity 16 | 26598-36-7 | C3H7O3P |
| Fosfomycin Impurity 17 | 25383-05-5 | C11H23O3P |
| Fosfomycin Impurity 20 | 25383-06-6 | C3H7O3P |
| Fosfomycin Impurity 21 | 6833-67-6 | C3H7O3P |
| Fosfomycin Impurity 22 | 34163-96-7 | C3H5O3P |
| Fosfomycin Trometamol EP Impurity A | 84954-80-3 | C3H9O5P |
| Fosfomycin Trometamol EP Impurity A-R,R | 132125-60-1 | C3H9O5P |
| Fosfomycin Trometamol EP Impurity B | 1262243-11-7 | C7H18NO7P |
| Fosfomycin Trometamol EP Impurity C | 23001-39-0 | C4H12NO6P |
| Fosfomycin Trometamol EP Impurity D | 1262243-12-8 | C10H25NO11P2 |
| Fosfomycin trometamol impurity A | Not available | C7H20NO8P |
| Fosfomycin tromethamine Impurity1 | 114252-50-5 | C4H10BaNO6P |
| Fosfomycin tromethamine Impurity2 | 25030-76-6 | C3H7O4P |
| Fosfomycin tromethamine Impurity 7 | 28423-96-3 | C7H15O4P |
| Fosinopril EP Impurity E | Not available | C30H40NO7P |
| Fosinopril Impurity 1 | 88889-14-9 | C30H45NNaO7P |
| Fosinopril Impurity 9 | 1421283-57-9 | C14H23NO3 |
| Fosinopril Impurity 11 | 72651-25-3 | C3H7O4P |
| Fosinopril Impurity 13 | 123599-78-0 | C19H29O6P |
| Fosinopril Impurity (HCl) | 90657-55-9 | C11H20ClNO2 |
| Fosinopril Impurity A | 95399-71-6 | C23H34NO5P |
| Fosinopril impurity B | Not available | C60H92N2O14P2 |
| Fosinopril impurity B | Not available | C60H92N2O14P2 |
| Fosinopril impurity C | 474519-28-3 | C30H46NO7P |
| Fosinopril impurity C | Not available | C30H46NO7P |
| Fosinopril impurity D | Not available | C30H46NO7P |
| Fosinopril Impurity D | 128948-00-5 | C19H29O6P |
| Fosinopril impurity I | 123599-82-6 | C19H29O6P |
| Fosinopril impurity I | 123599-82-6 | C19H29O6P |
| Fosinopril impurity I | 123599-82-6 | C19H29O6P |
| Fosinopril impurity K | Not available | C16H27NO3 |
| Fosinopril Related Compound A | 95399-71-6 | C23H34NO5P |
| Fosinopril Related Compound D ((4R)- 4-cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpro- poxy](4-phenylbutyl)phosphinyl]acetyl-L-proline propionate (ester), sodium salt) | Not available | C30H45NNaO7P |
| Fosinopril Related Compound G | 83623-61-4 | C12H17O4P |
| Fosinopril Related Compound H | 46348-61-2 | C10H15O3P |
| FR 179642 | 168110-44-9 | C35H52N8O20S |
| FR 901379 | 144371-88-0 | C51H82N8O21S |
| Framycetin Trisulphate | 4146-30-9 | C23H52N6O25S3 |
| Frovatriptan | 158747-02-5 | C14H17N3O |
| Frovatriptan Impurity 3 | 473927-51-4 | C7H9N3O |
| Frovatriptan Impurity 4 | 107431-14-1 | C13H25NO2 |
| Frovatriptan Related Compound A | 147008-88-6 | C13H15N3O |
| Fructosazine | 13185-73-4 | C12H20N2O8 |
| Fudosteine | 13189-98-5 | C6H13NO3S |
| Fudosteine impurity 1 | 50727-79-2 | C9H18N2O4S2 |
| Fudosteine Impurity 1 | 209665-22-5 | C6H13NO4S |
| Fudosteine Impurity 2 | 1480319-53-6 | C6H13NO5S |
| Fudosteine Impurity 3 | 1023971-15-4 | C6H13NO3S |
| Fudosteine impurity 4 | 1023971-10-9 | C6H13NO3S |
| Fudosteine Impurity 6 | 30453-21-5 | C6H14O2S2 |
| Fudosteine impurity 6 | 19721-22-3 | C3H8OS |
| Fulvestrant 9-Sulfone | 98008-06-1 | C32H47F5O4S |
| Fulvestrant EP Impurity A | 407577-53-1 | C32H47F5O3S |
| Fulvestrant EP Impurity B | 98008-06-1 | C32H47F5O4S |
| Fulvestrant EP Impurity C | Not available | C41H65F5O4S2 |
| Fulvestrant EP Impurity C | 2482852-42-4 | C41H65F5O4S2 |
| Fulvestrant EP Impurity D | Not available | C45H64O4 |
| Fulvestrant EP Impurity E | 2170200-14-1 | C32H45F5O3S |
| Fulvestrant EP Impurity F | Not available | C32H45F5O4S |
| Fulvestrant for system suitability | 129453-61-8 | C32H47F5O3S |
| Fulvestrant Impurity 1 | 2170200-16-3 | C32H45F5O2S |
| Fulvestrant Impurity 3 | 252947-01-6 | C6H9F5O3S |
| Fulvestrant Impurity 5 | 2490287-82-4 | C29H43ClO3 |
| Fulvestrant Impurity 10 | 1807900-80-6 | C32H47F5O3S |
| Fulvestrant Impurity 40 | 875573-60-7 | C35H60O4Si |
| Fulvestrant Impurity 45 | 30956-28-6 | C2H5ClN2O |
| Fumaric Acid Impurity 3 | 4749-70-6 | C7H10O4 |
| Fumaric acid monomethyl ester-D3 | 1616345-41-5 | C5H6O4 |
| Fumarprotocetraric acid | 489-50-9 | C22H16O12 |
| Furaltadone N-Oxide Hydrochloride | Not available | C13H17ClN4O7 |
| Furatheophylline | 80288-49-9 | C12H12N4O3 |
| Furazolidone Impurity 1 | 80-65-9 | C3H6N2O2 |
| Furfural | 98-01-1 | C5H4O2 |
| Furfural impurity 1 (5-methylfuranal) | 620-02-0 | C6H6O2 |
| Furfural Impurity 3 | 7389-38-0 | C12H10O5 |
| Furfural Impurity 5 | 59173-59-0 | C5H4O3 |
| Furfural Impurity 10 | 216144-29-5 | C9H14O3 |
| Furfural Impurity 13 | 107997-80-8 | C5H4O3 |
| Furfural Impurity 14 | 2074-02-4 | C11H8N4O5 |
| Furfural Impurity 16 | 42061-89-2 | C6H3NO2 |
| Furfural Impurity 17 | 21921-76-6 | C5H3BrO2 |
| Furfural Impurity 19 | 52480-43-0 | C7H8O2 |
| Furfural Impurity 20 | 23074-10-4 | C7H8O2 |
| Furfural-D4 | 1219803-80-1 | C5H4O2 |
| Furfuryl Alcohol | 98-00-0 | C5H6O2 |
| Furosemide EP Impurity A | 4818-59-1 | C12H11ClN2O5S |
| Furosemide EP Impurity B | 2736-23-4 | C7H5Cl2NO4S |
| Furosemide EP Impurity C | 3086-91-7 | C7H7ClN2O4S |
| Furosemide EP Impurity D | 5046-19-5 | C17H17N3O6S |
| Furosemide EP Impurity E | 50-84-0 | C7H4Cl2O2 |
| Furosemide EP Impurity F | 4793-38-8 | C12H15ClN2O5S |
| Furosemide Impurity 7 | 133989-65-8 | C12H12N2O6S |
| Furosemide Impurity 8 | 62574-66-7 | C7H3Cl3O3S |
| Furosemide Impurity 08 | 4818-85-3 | C12H12N2O5S |
| Furosemide Impurity 15 | 41332-59-6 | C7H4Cl2O5S |
| Furosemide Impurity 16 | 4753-68-8 | C5H8ClNO |
| Furosemide Impurity 23 | 72967-59-0 | C18H19ClN2O11S |
| Furosemide Impurity 25 | 98966-14-4 | C16H16N2O4 |
| Furosemide Impurity 27 | Not available | C7H6Cl2N2O3S |
| Furosemide Impurity 32 | 2760-11-4 | C7H6Cl2N2O3S |
| Furosemide Impurity 33 | 18240-50-1 | C10H11NO2 |
| Furosemide Impurity 34 | 3740-18-9 | C7H3Cl3O4S |
| Furosemide Impurity 37 | 4847-36-3 | C8H7Cl2NO4S |
| Furosemide Impurity 43 | 2309462-39-1 | C12H10ClNO6S |
| Furosemide Impurity 44 | 4793-47-9 | C12H12ClN3O4S |
| Furosemide impurity A | 4818-59-1 | C12H11ClN2O5S |
| Furosemide Related Compound A | 4818-59-1 | C12H11ClN2O5S |
| Furosemide Related Compound B | 3086-91-7 | C7H7ClN2O4S |
| Fusidic acid (sodium salt) | 751-94-0 | C31H47NaO6 |
| Fusidic acid EP Impurity B | Not available | C31H48O7 |
| Fusidic acid EP Impurity G | 4680-37-9 | C31H46O6 |
| Fusidic acid EP Impurity H | 16711-91-4 | C31H46O6 |
| Fusidic acid EP Impurity J | 13011-12-6 | C29H44O4 |
| Fusidic acid EP Impurity K | 4701-54-6 | C29H44O4 |
| Fusidic acid EP Impurity L | 74048-41-2 | C31H46O5 |
| Fusidic Acid EP Impurity O | 13090-91-0 | C29H46O5 |
| Fusidic acid EP Impurity O Sodium Salt | 55601-53-1 | C29H45NaO5 |
| Fusidic acid for peak identification | 6990-06-3 | C31H48O6 |
| Fusidic acid impurity 5 | 16391-75-6 | C35H59NO8 |
| Gabapentin EP impurity A | 64744-50-9 | C9H15NO |
| Gabapentin EP impurity B | 133481-09-1 | C9H13NO2 |
| Gabapentin EP impurity D | 1076198-17-8 | C18H29NO3 |
| Gabapentin EP impurity E | 67950-95-2 | C9H14O4 |
| Gabapentin EP impurity G | 1500558-49-5 | C10H19NO2 |
| Gabapentin Ethyl Ester Hydrochloride | 60175-04-4 | C11H22ClNO2 |
| Gabapentin Imp. A (EP): 2-Azaspiro[4.5]decan-3-one (3,3-Pentamethylene-4-butyrolactam) | 64744-50-9 | C9H15NO |
| Gabapentin Imp. E (EP): 1-(Carboxymethyl)cyclo- hexanecarboxylic Acid | 67950-95-2 | C9H14O4 |
| Gabapentin Impurity 2 | 4355-15-1 | C12H13N3O2 |
| Gabapentin impurity 5 | 1990449-64-3 | C21H35NO11 |
| Gabapentin impurity A | 64744-50-9 | C9H15NO |
| Gabapentin impurity B | 133481-09-1 | C9H13NO2 |
| Gabapentin impurity D | 1076198-17-8 | C18H29NO3 |
| Gabapentin Methyl Ester Hydrochloride | 63562-01-6 | C10H20ClNO2 |
| Gabapentin Related Compound A | 64744-50-9 | C9H15NO |
| Gabapentin Related Compound B | 133481-09-1 | C9H13NO2 |
| Gabapentin Related Compound D | 1076198-17-8 | C18H29NO3 |
| Gabapentin Related Compound E | 67950-95-2 | C9H14O4 |
| Gabapentin Related Compound E (Carboxymethyl-cyclohexanecarboxylic acid) | Not available | C9H14O4 |
| Gabapentine Impurity 8 | 103985-51-9 | C10H18O2 |
| Gabapentine Impurity 9 | 63562-01-6 | C10H20ClNO2 |
| gaboxado hydrochloride | 85118-33-8 | C6H9ClN2O2 |
| Gadobutrol EP Impurity A | 2514736-58-2 | C20H40N4O10 |
| Gadobutrol EP Impurity B | 138168-36-2 | C18H34N4O9 |
| Gadobutrol EP Impurity C | 112188-16-6 | C14H22GdN4O6- |
| Gadobutrol impurity 1 | 60239-18-1 | C16H28N4O8 |
| Gadobutrol impurity 2 | 72573-82-1 | C16H25GdN4O8 |
| Gadobutrol impurity 3 | 138884-14-7 | C17H32N4O7 |
| Gadobutrol impurity 4 | 112193-75-6 | C12H24N4O4 |
| Gadobutrol impurity 5 | 137076-50-7 | C24H44N4O8 |
| Gadobutrol impurity 6 | 1003-83-4 | C7H12O2 |
| Gadobutrol impurity 12 | 119167-08-7 | C20H44N4O4 |
| Gadobutrol impurity 14 | 229312-34-9 | C12H24N4O4 |
| Gadobutrol impurity 15 | 1822607-61-3 | C10H20N4 |
| Gadobutrol impurity 16 | 1151512-26-3 | C7H14O4 |
| Gadobutrol impurity 18 | 214195-92-3 | C10H20N4 |
| Gadobutrol impurity 20 | 214196-05-1 | C12H22N4 |
| Gadobutrol impurity 22 | 2349341-85-9 | C18H34N4O9 |
| Gadobutrol impurity 25 | 114873-37-9 | C14H26N4O6 |
| Gadobutrol impurity 29 | 402829-41-8 | C7H15NO3 |
| Gadobutrol impurity 31 | 188923-20-8 | C7H15NO3 |
| Gadobutrol impurity 32 | 69713-21-9 | C6H10Br2O2 |
| Gadobutrol impurity 34 | 170454-90-7 | C10H22N4O2 |
| Gadobutrol impurity 36 | 289719-40-0 | C15H26N4O2S |
| Gadobutrol impurity 37 | 245486-50-4 | C34H64N4O10 |
| Gadobutrol impurity 38 | 2919750-63-1 | C12H22N4 |
| Gadodiamide impurity A | Not available | C15H22GdN4NaO9 |
| Gadodiamide impurity B | 92923-64-3 | C14H18GdN3Na2O10 |
| Gadodiamide impurity B | 80529-93-7 | C28H54GdN5O20 |
| Gadolinium Diethylenetriaminepentaacetic Acid Monomethylamide Sodium Salt | Not available | C15H22GdN4NaO9 |
| Gadopentetic Acid Disodium Salt | 92923-64-3 | C14H18GdN3Na2O10 |
| Gadoteridol Related Compound A | 120041-08-9 | C17H32N4O7 |
| Gadoteridol Related Compound A (10- (2-hydroxypropyl)-1,4,7,10-tetraazacyclodode- cane-1,4,7-triacetic acid) | Not available | C17H32N4O7 |
| Gadoteridol Related Compound B | 112188-16-6 | C14H22GdN4O6- |
| Gadoteridol Related Compound B (1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, monogadolinium salt) | Not available | C14H23GdN4O6 |
| Gadoteridol Related Compound C | 220182-19-4 | C14H24N4O5 |
| Gadoxetate Disodium | 135326-22-6 | C23H28GdN3Na2O11 |
| Gadoxetate Disodium Impurity 3 | 158599-72-5 | C23H33N3O11 |
| Gadoxetate Disodium Impurity 9 | 1618674-24-0 | C17H27NO6S |
| Gadoxetate Disodium Impurity 10 | 1419101-00-0 | C11H20ClN3O |
| Gadoxetate Disodium Impurity 11 | 200267-69-2 | C11H17NO2 |
| Gadoxetate Disodium Impurity 12 | 158703-75-4 | C23H28GdN3Na2O11 |
| Gadoxetate Disodium Impurity 14 | 1512540-67-8 | C23H28N3Na5O11 |
| Gadoxetate Disodium Impurity 17 | 867-64-1 | C6Gd2O12 |
| Galactitol | 608-66-2 | C6H14O6 |
| Galactose miglitol | 1322625-07-9 | C8H18ClNO5 |
| Galactose uronic acid | 685-73-4 | C6H10O7 |
| Galantamine EP impurity A | 510-77-0 | C17H19NO3 |
| Galantamine EP impurity B | 1668-85-5 | C17H21NO3 |
| Galantamine EP impurity C | 21133-52-8 | C17H23NO3 |
| Galantamine EP impurity D | 664995-65-7 | C17H19NO2 |
| Galantamine EP impurity E | 41303-74-6 | C16H19NO3 |
| Galantamine EP impurity F | 60384-53-4 | C17H21NO3 |
| Galantamine Hydrobromide Impurity Standard | 1953-04-4 | C17H22BrNO3 |
| Galantamine impurity 5 | 60755-80-8 | C16H19NO3 |
| Galantamine impurity 6 | 134332-50-6 | C17H21NO4 |
| Galantamine impurity 7 | 21041-10-1 | C17H21NO3 |
| Galantamine impurity 9 | 199014-26-1 | C17H21NO4 |
| Galantamine natural for system suitability | 1953-04-4 | C17H22BrNO3 |
| Galantamine racemic mixture | 1953-04-4 | C17H22BrNO3 |
| Galantamine synthetic for system suitability | 1953-04-4 | C17H22BrNO3 |
| Galanthaminone | 510-77-0 | C17H19NO3 |
| galegine | 543-83-9 | C6H13N3 |
| Gamithromycin Impurity 1 | 145388-07-4 | C37H70N2O12 |
| gamma-Butyrolactone (GBL) | 96-48-0 | C4H6O2 |
| gamma-Oxo-3-pyridinebutyric Acid | 4192-31-8 | C9H9NO3 |
| Ganaxolone Impurity 1 | 1264737-31-6 | C22H36O2 |
| Ganciclovir Di-O-acetate | 86357-19-9 | C13H17N5O6 |
| Ganciclovir EP Impurity A | 1797982-93-4 | C9H10ClN5O2 |
| Ganciclovir EP Impurity B | 194159-18-7 | C12H17N5O5 |
| Ganciclovir EP Impurity C | 108436-36-8 | C9H12ClN5O3 |
| Ganciclovir EP Impurity E | 86357-09-7 | C9H13N5O4 |
| Ganciclovir EP Impurity H | 84222-50-4 | C9H13N5O4 |
| Ganciclovir EP Impurity I | 86357-20-2 | C15H21N5O6 |
